Madison.com: Cellectar Biosciences’ quarterly loss holds steady

Cellectar Biosciences, Madison, reported a net loss of $2.1 million, or 49 cents a share, for the second quarter that ended June 30 compared with a net loss of $2.3 million, or $3.02 a share, for the same period last year. The results were impacted by a one-for-10 reverse stock split — or one stock for every 10 held — enacted in March. Read the full story here.